What is the ROE (Return on Equity) of Spineway this year?
The ROE of Spineway this year is -0.34 undefined.
Spineway ROE 2024
Spineway ROE
-0.34
Ticker
ALSPW.PA
ISIN
FR0011398874
WKN
A1KCX1
In 2024, Spineway's return on equity (ROE) was -0.34, a 139.7% increase from the -0.14 ROE in the previous year.
Spineway Aktienanalyse
What does Spineway do?
Spineway SA is an internationally active company specializing in the development and marketing of innovative solutions in the field of spinal surgery. The company was founded in France in 2005 and has since expanded its business to be present in over 40 countries. The business model of Spineway is based on strong research and development capabilities as well as a close network of partners such as hospitals and surgeons. The goal is to continuously analyze the needs of patients and the challenges of modern spinal surgery and develop innovative solutions that enable doctors to perform their work more precisely and safely. Spineway specializes in three main areas: instrumentation, biomaterials, and spinal health. It offers a wide range of instruments, from screws to implants, that can be used in the lumbar, thoracic, and cervical spine. The company works closely with surgeons to develop specific solutions and instruments that meet the individual needs of patients. In addition, Spineway develops and produces its own biomaterials, which are used in various products such as screws and cages that are implanted in the spine. The company has developed a customized production line to ensure the highest possible quality of its biomaterials. Spineway is also committed to improving spinal health through innovative solutions and patient and physician education. The company has developed various programs to raise awareness among patients about how to maintain and improve the health of their spine. Some of Spineway's most well-known products include spinal surgery solutions such as the Mont-Blanc All-in-One Steering and K-Fix Steering, as well as a wide range of cages and screws made from their own biomaterials. Additionally, Spineway has developed products for the transplantation of cartilage and connective tissue. Over the years, Spineway has achieved several important milestones. The company has been listed on the Paris Stock Exchange since 2011 and has expanded its global presence in recent years through the opening of subsidiaries in the US, Mexico, and Brazil, as well as strategic partnerships in Asia and the Middle East. In summary, Spineway holds a leading position in the spinal surgery market and continues to focus on constantly searching for innovative solutions to maximize returns for its investors and improve the lives of patients. Spineway ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Spineway's Return on Equity (ROE)
Spineway's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Spineway's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Spineway's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Spineway’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Spineway stock
How has the Return on Equity (ROE) of Spineway developed compared to the previous year?
The ROE of Spineway has increased by 139.7% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Spineway?
A high ROE indicates that Spineway generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Spineway?
A low ROE can indicate that Spineway is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Spineway affect the company?
A change in ROE (Return on Equity) of Spineway can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Spineway?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Spineway?
Some factors that can influence Spineway's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Spineway pay?
Over the past 12 months, Spineway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Spineway is expected to pay a dividend of 0 EUR.
What is the dividend yield of Spineway?
The current dividend yield of Spineway is .
When does Spineway pay dividends?
Spineway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Spineway?
Spineway paid dividends every year for the past 0 years.
What is the dividend of Spineway?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Spineway located?
Spineway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Spineway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spineway from 11/8/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did Spineway pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of Spineway in the year 2023?
In the year 2023, Spineway distributed 0 EUR as dividends.
In which currency does Spineway pay out the dividend?
The dividends of Spineway are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spineway
Our stock analysis for Spineway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spineway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
